High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

Association of CTLA4 and PD-L1 immunohistchemical expression with various clinicopathological parameters and survival in non–small-cell lung cancer

High expression of the checkpoint molecule PD-1 on regulatory and helper CD4+ T cells in metastatic breast cancer patients with poor prognosis

Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

Role of YAP1 and tumor-associated macrophages in urothelial carcinoma of urinary bladder: Histopathological and immunohistochemical studies

Immunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological

Assessment of PI3KCA immunohistochemical expression and tumor infiltrating lymphocytes (CD4 and CD8) in invasive breast carcinoma and their relation to molecular subtypes

Immunohistochemical Expression of PDL1 in Invasive Ductal Carcinoma of the Breast

Immunohistochemical Study of PDL-1 Expression in Urinary Bladder Carcinoma

Evaluation of Histopathological and Prognostic Significance of Programmed Death Ligand 1 (PD-L1) Expression of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma